Compare CVS Health Corp (CVS) vs Gap Inc (GAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Gap Inc — how do they compare? CVS Health Corp trades at $86.16 (market cap $112.29B), while Gap Inc trades at $23.23 (market cap $8.21B). The key difference: CVS Health Corp is far larger — about 13.7× Gap Inc's market cap, and CVS Health Corp pays the higher dividend (3.03%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Gap Inc for 37 Days on average.
| CVS | GAP | |
|---|---|---|
Market Cap | $112.29B | $8.21B |
Volume | 7,763,676 | 5,192,917 |
Sector | Health | Consumer Cyclical |
52-Week High | $110.60 | $29.13 |
52-Week Low | $70.08 | $18.35 |
Typical Hold Time | 83 Days | 37 Days |
Enterprise Value | $174.64B | $11.44B |
Dividend Yield | 3.03% | 3% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, down 0.17% on the day, with a bearish technical signal and neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.58 exceeding the $1.85 estimate. Revenue grew to $402.07B in 2025, though net income margin compressed to 1.18%. Recent news highlights Aetna's 2027 Medicare plan updates and a quarterly dividend declaration.
CVS presents a mixed outlook with solid revenue growth and analyst bullishness (85% buy ratings, $111.20 consensus target) offset by profitability pressures and a bearish technical trend. Key risks include reimbursement pressure and ongoing legal investigations, but the stock offers value with a low P/S of 0.27 and dividend yield support.
Gap trades at $23.36, down 1.06% on the day, with a bullish technical signal supported by moving averages. The company shows strong profitability with a 43.26% gross margin and 33.78% ROE, while valuation ratios like a P/E of 7.04 and P/S of 0.58 suggest potential undervaluation. Recent earnings beats in Q1 and Q2 2026 and a new 'fashiontainment' partnership with boy band JYT highlight operational momentum.
The outlook is positive given earnings growth and low valuation, but risks include reliance on Old Navy's turnaround and competitive pressures. Analyst consensus is a $25.67 price target with a 'Hold' bias, indicating modest upside from current levels amid mixed institutional sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Gap Inc
Gap retails apparel, accessories, and personal-care products under the Gap, Old Navy, Banana Republic, and Athleta brands. Old Navy generates more than half of Gap's sales. The firm also operates e-commerce sites, outlet stores, and specialty stores under various Gap names. Gap operates nearly 3,000 stores in North America, Europe, and Asia and franchises about 600 stores in Asia, Europe, Latin America, and other regions. Gap was founded in 1969 and is based in San Francisco.
Read more on GAP →
